The medications used to treat lung diseases are diverse. While patient-specific factors can help determine course of treatment, there are larger considerations for the pharmacy management of lung conditions.
These diseases are infrequent, but they can incur significant costs as they can be present for life, requiring ongoing monitoring, treatment, and medication.
Dermatological agents remained a significant cost driver, in part due to physician dispensing and delivery pharmacies, which accounted for a significant number of high-cost transactions.
More complex and costly claims have become a persistent issue in workers’ compensation. Understanding the contributors to claim complexity is the first step to mitigating and managing these claims.
